The current ACC Board of Trustees (BOT) consists of 15 individuals who took office in April 2022. The president of ACC leads the Trustees for a one-year term. See the full roster of BOT members and officers below:
Edward T.A. Fry, MD, FACC, President
Edward T.A. Fry, MD, FACC, attended medical school at Washington University School of Medicine in St. Louis and completed his residency in internal medicine at Barnes-Jewish Hospital. He completed a two-year cardiovascular research fellowship focused on pharmacokinetics/pharmacodynamics of native and genetically modified plasminogen activators. He also completed a general cardiology fellowship at Washington University, where he then served as assistant professor and medical director of the cardiac transplant program before completing an interventional cardiology fellowship at Ascension St. Vincent Hospital – Indianapolis.
In 1991, he joined the cardiology practice at St. Vincent where he continues to be a busy interventional and general cardiologist and serves as chair of the Ascension National Cardiovascular Service Line. He helped launch Navion Healthcare Solutions, a subsidiary data quality management software company owned by Ascension, where he previously served as board chair.
Dr. Fry is past president and governor of ACC's Indiana Chapter. Within the ACC, he has served on the Audit and Compliance Committee (chair), Digital Strategy Steering Committee; Interventional Section Leadership Council; Surviving MI Initiative; Integrating the Health Enterprise Health Policy Work Group; Clinical Quality Committee; Prior Authorization Work Group; ACC Telemedicine Project; ACC COVID-19 Hub; Board of Governors Steering Committee; Innovations Development Work Group; ACC Premier Oversight Work Group (chair); Board of Trustees (BOT) Task Force on Clinician Well-Being; Health Systems Task Force; ACC/AHA Ethics and Professionalism Consensus Task Force, and ACC Nominating Committee. He has been a presenter, moderator and session chair at ACC Annual Scientific Session, ACC CV Summit, MedAxiom CV Transforum, Heart House Roundtables and is a member of HeartPAC, ACC's political action committee.
He currently serves on ACC's BOT and MedAxiom's Board of Managers.
B. Hadley Wilson, MD, FACC, Vice President
B. Hadley Wilson, MD, FACC, is an interventional cardiologist and executive vice chair at Sanger Heart and Vascular Institute in North Carolina, where he previously served as chief of cardiology for more than 13 years. He has published more than 75 articles with interests spanning STEMI systems of care, stent technologies and devices for coronary intervention, left main stenting, chronic total occlusions, anticoagulation and antiplatelet therapies, structural and valvular heart disease, appropriate public reporting of PCI outcomes and quality improvement projects for systems of care, and clinician well-being.
Wilson graduated with honors from Davidson College and subsequently Duke University School of Medicine. He then trained in internal medicine at Vanderbilt University Medical Center, where he served as chief resident before completing his cardiology fellowship under Gottlieb Friesinger, MD, FACC. Since 2006, he has been a clinical professor of medicine at the University of North Carolina School of Medicine, as well as the chief liaison for cardiovascular training between UNC's hospital campuses in Charlotte and Chapel Hill. Wilson served as co-director of the annual Advanced Cardiovascular Interventions course in Hilton Head, SC, from 1992-2007 and as the chief interventional cardiologist for the ACC North Carolina Chapter STEMI/RACE program to develop a statewide system of care from 2005-2015. From 2011-2020, he was the chair of the ACC/American Heart Association National STEMI Accelerator I and II programs, covering more than 30 million lives.
Since 2019, he has been a senior adviser to the steering committee for the ACC Global Heart Attack Treatment Initiative, enrolling more than 2,000 STEMI patients. Wilson has also led numerous cardiology medical missions to other countries, including Haiti, Panama, Nicaragua and Honduras. Wilson is co-chair of ACC Latin America, a position he has held since 2020, and is the ACC ambassador to Mexico. In the past, he has served as governor for ACC's North Carolina Chapter, as well as chair of the Board of Governors and secretary of the Board of Trustees. He also has held positions on the ACC Membership Committee and the NCDR Management Board and has served as chair-elect of the Governance Committee.
Dipti Itchhaporia, MD, MACC, Immediate-Past President
Dipti Itchhaporia, MD, MACC, is an interventional cardiologist and the Eric & Sheila Samson Endowed Chair in Cardiovascular Health, director of disease management for Hoag Heart and Vascular Institute, and associate professor at the University of California, Irvine, School of Medicine. Dr. Itchhaporia completed her residency in internal medicine at Stanford Health Care, as well as fellowships in cardiology at Georgetown University Medical Center and in interventional cardiology at Stanford Health Care.
Dr. Itchhaporia's professional interests include quality measurement and improvement and cardiovascular disease prevention in women. Most recently, she has focused on technology and innovations that can propel digital transformation and disrupt care delivery, ultimately improving the lives of clinicians and patients and helping achieve health equity. She has been the chair of ACC's Task Force on Health Equity focusing on addressing issues of health disparities and social determinants of health and improving access to care for underserved patients.
As an educator, Dr. Itchhaporia is interested in increasing the global awareness of cardiovascular disease and promoting health equity. She has worked with the Public Health Foundation of India in capacity-building efforts to develop and update content for certificate courses in cardiovascular disease and stroke prevention. She has been involved with the Best of ACC program in China, which aims to educate cardiovascular professionals throughout the country. She was co-chair of the ACC Middle East Conference in 2019 and 2020 and is on the editorial board for ACC's extended learning (ACCEL). She also serves on the editorial board of Cardiology Today magazine.
Dr. Itchhaporia served on ACC's Board of Trustees, as secretary and chair of the Board of Governors, as well as president of ACC's California Chapter. She went on to serve as vice president and president of the College. She also served on ACC's Lifelong Learning Oversight Committee, Science and Quality Committee, Governance Committee, Practice Administrator Workgroup and the ACC Innovation Program. She also has held several leadership positions with the American Heart Association (AHA).
Dr. Itchhaporia is a fellow of the ACC, AHA and European Society of Cardiology, as well as an honorary member of the British Cardiovascular Society and the Indian College of Cardiology. She was named a Top Doctor by Orange Coast Magazine and has been recognized by the AHA as an Outstanding Medical Honoree.
Christopher Kramer, MD, FACC, Treasurer
Christopher Kramer, MD, FACC, received his medical degree from the University of California, San Francisco, School of Medicine, and completed residency and chief residency in internal medicine and fellowship in cardiology at the Hospital of the University of Pennsylvania. His first faculty appointment was at Allegheny General Hospital and MCP/Hahnemann University School of Medicine, now Drexel University College of Medicine, where he directed the cardiology fellowship program. In 1999, he moved to the University of Virginia School of Medicine, where, in 2019, he was named the George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine and chief of the Division of Cardiovascular Medicine.
Dr. Kramer's principal research interest has been the application of cardiovascular magnetic resonance (CMR) to the cardiovascular system in studies ranging from mice to large animals to humans. He has published more 250 peer-reviewed publications; four books; and more than 100 book chapters, editorials and reviews on the topics of left ventricular remodeling and myocardial viability, atherosclerotic plaque imaging, peripheral arterial disease (PAD) and hypertrophic cardiomyopathy (HCM). Dr. Kramer has received National Institutes of Health (NIH) R01 funding for research on CMR of PAD and is co-principal investigator of a 2,755 patient, 44-site international registry study, funded by the National Heart, Lung, and Blood Institute. In addition, he directs a cardiovascular fellowship program, funded by the National Institute of Biomedical Imaging and Bioengineering.
He is treasurer-elect of the ACC. He is a past president of the Society for Cardiovascular Magnetic Resonance (SCMR) and previously served as chair of ACC's Imaging Council, as well as chair of the Clinical and Integrative Cardiovascular Sciences NIH study section.
Dr. Kramer previously served on the editorial board of JACC: Cardiovascular Imaging and currently serves on the editorial boards of Circulation, Circulation: Cardiovascular Imaging and Vascular Medicine. He is also member of the American Society for Clinical Investigation, Association of University Cardiologists and American Association of Physicians. Dr. Kramer received the Gold Medal from the SCMR in 2015 and was named a Distinguished Mentor by the ACC in 2021.
Malissa Wood, MD, FACC, Secretary and BOG Chair
Malissa Wood, MD, FACC, completed her undergraduate and medical degrees at the University of Missouri-Kansas City School of Medicine, followed by training in internal medicine and cardiovascular medicine at Beth Israel Deaconess Medical Center/Harvard Medical School, where she was chief medical resident. Dr. Wood joined the staff of Massachusetts General Hospital (MGH) in 2000. She currently holds the Cathy E. Minehan Chair of Cardiovascular Disease in Women, co-directs the Corrigan Women's Heart Health Program, and serves as medical director of the MGH North Shore Ambulatory Cardiology practice in Danvers, MA.
Dr. Wood's research has focused on cardiovascular disease in women. She has studied cardiovascular adaptation to exercise training to better understand complex sex differences in heart function. This work, which described features of temporary left- and right-sided cardiac changes that occur after completion of a marathon, has been frequently cited.
Dr. Wood helped design and implement the Corrigan Women's Heart Health Program in 2007, with the goal of improving clinical care and understanding of cardiovascular disease in women. The program has helped improve the cardiovascular health of thousands of women and their families through its clinical, research and educational efforts. Dr. Wood's groundbreaking work on the HAPPY Heart study demonstrated the benefit of an integrated community-based model of stress management, health and life coaching and group health education in low-income women, resulting in the publication of two books – Smart at Heart and Thinfluence.
Dr. Wood has made significant educational contributions devoted to raising awareness of gender differences in cardiovascular disease risk, symptoms and prevention strategies. She served as a member of the American Heart Association writing group on the current state of spontaneous coronary artery dissection and as co-editor of the textbook Sex Differences in Cardiac Disease. She also served on the ACC Women in Cardiology Section Leadership Council. In addition, she has been involved in successful advocacy efforts at the state and national levels and currently serves on the Executive Committee of ACC's HeartPAC.
Dr. Wood is a current member of the ACC Cardiovascular Disease in Women Committee.
Cathleen Biga, MSN, RN, FACC, Trustee
Cathleen Biga, MSN, RN, FACC, is president and CEO of Cardiovascular Management of Illinois, a cardiology physician practice management company. She works with more than 100 providers in the Chicago, IL, area and partners in their cardiovascular service lines at more than 14 acute care hospitals. She earned her Bachelor of Science degree in nursing from the Mayo/College of St. Teresa and Master of Science in nursing at Northern Illinois University School of Nursing.
Ms. Biga has more than 40 years of experience as a registered nurse, service line director, hospital vice president and CEO. She has 20 years of experience in physician practice management.
She has been active nationally in consulting in strategic planning, operational efficiencies, integrated financial and quality initiatives, and growth and development of the cardiovascular service lines. She is focused on facilitating the integration of strategic, financial and quality perspectives between cardiovascular service lines at practices and hospitals. In addition, she consults and lectures on numerous contemporary cardiovascular topics.
Ms. Biga is a member of ACC's Board of Trustees, chair of the MedAxiom Board of Managers, a member of the American Association of Cardiovascular and Pulmonary Rehabilitation and an ACC fellow.
Ed W. Childs, MD, FACS, Public Member Trustee
Ed W. Childs, MD, FACS, is a professor and chair of surgery at Morehouse School of Medicine. He received his bachelor's degree in molecular and cellular biology from the University of Texas at Dallas and his medical degree from Texas A&M University College of Medicine. He completed postgraduate training in general surgery at the University of Kansas Medical Center and a fellowship in trauma/critical care at UC Davis Health . Dr. Childs co-edited the book Stigma and Prejudice with ACC Diversity and Inclusion Director Ranna Parekh, MD, MPH, and co-authored The Massachusetts General Hospital Textbook on Diversity and Cultural Sensitivity in Mental Health. He serves as a public member of ACC's Board of Trustees.
Pamela B. Morris, MD, FACC, Trustee
Pamela B. Morris, MD, FACC, is Professor of Medicine and Cardiology at The Medical University of South Carolina, where she is Director of the Seinsheimer Cardiovascular Health Program and Co-Director of Women's Heart Care.
Dr. Morris is a fellow of the American College of Cardiology, the American Heart Association, the American Society of Preventive Cardiology, and the National Lipid Association. She served as Vice Chair of the ACC Annual Scientific Sessions, ACC.19 and ACC.20 Together with the World Congress of Cardiology, and as Chair of ACC.21 and ACC.22. She currently serves as an Associate Editor of the Journal of the American College of Cardiology. Her interests are focused in Preventive Cardiology, Clinical Lipidology, Preventive Imaging, Global Health Promotion, and Clinician Education. She was the first Chair of the ACC Prevention of Cardiovascular Disease Leadership Council and Section. She was previously Chair of the ACC Heart House Roundtable Committee and has developed and participated in a number of roundtables to identify gaps in knowledge in cardiovascular disease prevention. She has served on a number of writing committees for ACC Expert Consensus Decision Pathways to provide practical clinical guidance for management of LDL-C, hypertriglyceridemia, tobacco cessation, and diabetes for ASCVD risk reduction.
James L. Januzzi, Jr., MD, FACC, Trustee
James L. Januzzi, MD, FACC, is the Hutter Family Professor of Medicine at Harvard Medical School and a staff cardiologist at Massachusetts General Hospital (MGH). After completing his undergraduate studies at Holy Cross College in 1988, Dr. Januzzi graduated as a top-ranked student at New York Medical College and completed a residency in internal medicine at Brigham and Women's Hospital and fellowship in cardiology and cardiac ultrasound at MGH. He joined the Cardiology Division at MGH in 2000.
Dr. Januzzi is a clinician and clinical researcher. He has an active general cardiology practice focused on patients with acute and chronic heart failure. He has made extensive contributions to the understanding of cardiac biomarker testing, where his research has set international standards for use in diagnosis, prognosis and management of patients suffering from acute and chronic heart failure, as well as in those with acute coronary syndromes.
He has contributed to numerous efforts at the ACC, serving as an associate editor for both the Journal of the American College of Cardiology and JACC: Heart Failure. He has also served as chair of the Task Force on Expert Consensus Decision Pathway Documents and co-chair of the Science and Quality Committee.
Jeffrey Kuvin, MD, FACC, Trustee
Jeffrey Kuvin, MD, FACC, is the Lorinda and Vincent de Roulet Professor of Medicine and chair of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is also chair of cardiology at North Shore University Hospital and Long Island Jewish Medical Center, co-director of the Sandra Atlas Bass Heart Hospital at North Shore University Hospital, and senior vice president of cardiology at Northwell Health. He earned his undergraduate degree from the University of Michigan and his medical degree from Emory University School of Medicine. He completed his residency and cardiology fellowship at Tufts Medical Center in Boston, MA.
Dr. Kuvin was recruited to Northwell in 2020 after serving as section chief of cardiovascular medicine at Dartmouth-Hitchcock Medical Center Heart and Vascular Center. Before joining Dartmouth, Dr. Kuvin served at Tufts Medical Center and Tufts University School of Medicine as associate chief medical officer for graduate medical education, associate chief of cardiology, director of cardiovascular quality, and director of cardiovascular education and fellowship training.
Dr. Kuvin is well-known for contributions in cardiovascular education and training. He was selected to the Geisel Academy of Master Educators at the Geisel School of Medicine at Dartmouth. In addition, he received a Career Award for Teaching Excellence at Tufts and has been listed numerous times as a Top Doctor in Boston Magazine.
At the ACC, Dr. Kuvin has served as chair of the Lifelong Learning Oversight Committee, as well as chair (2017 – 2018) and vice chair (2015 – 2016) of ACC's Annual Scientific Session. In addition, Dr. Kuvin was the lead developer and first chair of the ACC In-Training Exam and is a past editor of ACC's Adult Clinical Cardiology Self-Assessment Program (ACCSAP). He currently serves as an associate editor for the Journal of the American College of Cardiology.
Nicole L. Lohr, MD, PhD, FACC, BOG Chair-Elect
Nicole L. Lohr, MD, PhD, FACC, obtained her doctorate in physiology and medical degree from the Medical College of Wisconsin (MCW) in Milwaukee, WI. She went on to complete her residency and fellowship in cardiovascular medicine at MCW, where accepted a position as an assistant professor in the Division of Cardiovascular Medicine. She was promoted to associate professor in 2019.
Dr. Lohr has proven to be a dedicated clinician-researcher and health care administrator, with leadership roles as medical director of Cardiovascular Clinical Trials at Froedtert Hospital & the Medical College of Wisconsin (2015-present) and as chief of cardiovascular medicine at the Clement J. Zablocki VA Medical Center (2016-present).
Dr. Lohr is a physician-scientist, serving as principal investigator for numerous active clinical trials. She continues to actively recruit research participants for her National Institutes of Health R01-funded research, "Small molecule NO precursors as a bioactive source of NO in vasodilation and angiogenesis," which began in 2019. In addition, she has been a proud recipient of the VA MERIT Review Award Program for several years, with her current research focused on "Red light-mediated trafficking of microvesicles as a mechanism of vasodilation."
She currently holds leadership positions in with the ACC and American Heart Association (AHA). Dr. Lohr served as board president of AHA's Milwaukee Chapter in 2020 and earner her FACC designation in 2014. She also has served in ACC's Wisconsin Chapter as councilor (2015), governor-elect (2019), and governor (2020).
Roxana Mehran, MD, FACC, Trustee
Roxana Mehran, MD, FACC, is a professor of cardiovascular clinical research and outcomes, professor of medicine (cardiology), and population health science and policy at the Icahn School of Medicine at Mount Sinai. She is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. She completed fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center.
As director of the Center for Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has built a globally respected academic research center focused on developing randomized clinical trials, outcomes research projects and high-impact academic publications. She has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participated in development of clinical guidelines, and authored more than 1,200 peer-reviewed articles.
Dr. Mehran has been named by Clarivate Analytics as one of the most influential scientific minds and as a highly cited researcher. She is a founder and chief scientific officer of the Cardiovascular Research Foundation and recently founded Women as One, an independent nonprofit organization dedicated to advancing opportunities for women in medicine.
At the ACC, Dr. Mehran has served as chair of the Interventional Section Leadership Council. She also has been active in the Society for Cardiovascular Angiography and Interventions, where she served as program chair of the 2016 Scientific Sessions and co-founded the Women in Innovations Committee. In addition, Dr. Mehran was a member of the American Heart Association Go Red for Women Scientific Advisory Group. She has received several awards, including the 2017 ACC Bernadine Healy Leadership in CV Disease Award, the 2018 Nanette Wenger Award from Women'sHeart for excellence in medical leadership and the 2019 Ellis Island Medal of Honor.
Hani Najm, MD, FACC, Trustee
Hani Najm, MD, FACC, is an expert in congenital heart surgery and has performed more than 400 surgical cases per year on newborns, children and adults with the most complex heart disease. Dr. Najm spent 17 years developing the premier Pediatric Heart Center at King Abdulaziz Medical Center in Riyadh, Saudi Arabia, before joining the Cleveland Clinic in 2016 as the chair of pediatric and congenital heart surgery. He attended medical school at King Saud University Medical School in Saudi Arabia and completed training at the Toronto Hospital and the Hospital for Sick Children, both in Toronto, Canada.
Dr. Najm is an international lecturer in the field of congenital heart surgery and a collaborator in multiple research projects, including use of multicenter databases as a valuable tool for evidence-based practices in congenital heart disease.
In addition, Dr. Najm is a past president of the Saudi Heart Association and has previously served as editor-in-chief of the Journal of Saudi Heart Association, a member of the Saudi Medical Journal editorial board and associate professor at King Abdulaziz University for Health Sciences. He holds numerous memberships in national and international professional organizations.
Thomas M. Maddox, MD, MSc, FACC, Trustee
Thomas M. Maddox, MD, MSc, FACC, is the inaugural executive director of the Healthcare Innovation Lab at BJC HealthCare and Washington University School of Medicine in St. Louis. He attended Emory University School of Medicine and completed his residency at the University of Texas Southwestern Medical Center and a fellowship at Mount Sinai Medical Center. Dr. Maddox is a practicing cardiologist, a professor of medicine (cardiology) at the Washington University School of Medicine and a health services researcher.
As a researcher, Dr. Maddox's interests have focused on health care delivery innovation, learning health care systems, prevention of coronary artery disease, optimal care for cardiac patients undergoing noncardiac surgery, and quality of care for cardiac patients. The Healthcare Innovation Lab catalyzes care delivery innovation through research and development. To date, the Lab has developed innovations in predictive analytics in inpatient care, critical care and palliative care; remote patient monitoring in heart failure, post-operative and post-partum patients; patient transportation for ambulatory and cancer patients; voice assistants in inpatient supply chain and pre-operative patients; and patient billing.
Dr. Maddox has authored more than 230 peer-reviewed publications, received multiple grants exploring optimal cardiovascular care and outcomes, and holds national leadership positions at the ACC and American Heart Association.
Joseph E. Marine, MD, MBA, FACC, Trustee
Joseph E. Marine, MD, MBA, FACC, is a clinical cardiac electrophysiologist who practices at the Johns Hopkins Hospital in Baltimore, MD. He is a professor of medicine at the Johns Hopkins University School of Medicine and holds appointments as vice director of the Division of Cardiology and section chief of Cardiology for Johns Hopkins Community Physicians.
Dr. Marine received his medical degree at the University of California, San Francisco, School of Medicine and completed an internal medicine residency at Brigham and Women's Hospital/Harvard Medical School. He then went on to complete a cardiology fellowship at Boston Medical Center, as well as two fellowships in cardiac electrophysiology Beth Israel Deaconess Medical Center and Boston Medical Center.
As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, particularly catheter ablation of atrial fibrillation (AFib) and atrial flutter. His research focuses on improving the safety and effectiveness of catheter ablation and treatments for AFib, as well as other atrial and ventricular arrhythmias.
Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the ACC Cardiovascular Overview and Board Review Course for more than 10 years. He has served on several other committees for the ACC, the Heart Rhythm Society (HRS) and the Maryland State Medical Society. He is author or co-author of more than 150 peer-reviewed articles and has served on writing committees for numerous ACC clinical practice and training guidelines.
He currently serves as chair of the ACC Board of Governors and is co-editor of the ACC/HRS Electrophysiology Self-Assessment Program (EP SAP).